Detection of antibodies to hepatits C virus in dialysis patients
| Autor: | V Pirozzi, Daniela Rivanera, Carlo Mancini, V Cannulla, D. Lilli, G. Lorino, G. Dicuonzo |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Adult
Male medicine.medical_specialty Epidemiology medicine.medical_treatment Hepatitis C virus Immunoblotting Enzyme-Linked Immunosorbent Assay Hepacivirus medicine.disease_cause Serology Renal Dialysis Seroepidemiologic Studies Internal medicine Prevalence medicine Humans Hepatitis Antibodies Dialysis Aged Aged 80 and over Hepatitis B virus business.industry Incidence (epidemiology) Hepatitis C Antibodies Middle Aged Hepatitis C Italy Immunology Female Viral disease Hemodialysis business |
| Zdroj: | European Journal of Epidemiology. 9:55-58 |
| ISSN: | 1573-7284 |
| Popis: | Dialysis patients are at risk for infection by a variety of blood-borne agents transmitted within dialysis units. The development of the hepatitis C virus (HCV) screening test prompted many studies on the prevalence of anti-HCV among dialysis patients. The authors have evaluated the prevalence of anti-HCV in 405 hemodialysis patients both by Elisa screening and 4-RIBA test system with a follow-up of two years. The study showed a difference in the incidence of antibodies to HCV by year. In 1990, 15.2% were positive with an increase to 20.8% in 1991. There was an increase of 5% in dialysis patients and only 1.9% in the personnel working in the dialysis ward. Another control group of volunteers did not show any positivity. In addition, the correlations of the antibodies against HCV with markers of hepatitis B virus (HBV) and history of transfusion were evaluated. These findings suggest that the patients found to be positive should be dialyzed on separate machines and special precautions must be undertaken to reduce the risk of transmission. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink